Skip to content

Effects of use esketamine and dexmedetomidine during and after cesarean section on postpartum depression

Effects of use esketamine and dexmedetomidine during and after cesarean section on postpartum depression

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032648
Enrollment
Unknown
Registered
2020-05-04
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum depression

Interventions

Group K:Perioperative and postoperative analgesia pumps use of esketamine
Group KD:Perioperative and postoperative analgesia pumps use of esketamine and dexmedetomidine

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1) Maternal with ASA grade I-II; 2) Maternal for cesarean section; 3) Maternal age is 20 ~ 45 years old; 4) 28-42 weeks of gestational age; 5) Preoperative Edinburgh Postpartum Depression Rating Scale score > 9; 6) Single-born pregnant primipara; 7)Willing to participate in this trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Pregnancy through assisted reproduction; 2) Maternal women have serious obstetric complications or serious underlying diseases; 3) History of ketamine abuse or dependence, drug or alcohol dependence for more than 6 months; 4) Allergy to research related drugs; 5) With a history of mental illness or depression in other life stages.

Design outcomes

Primary

MeasureTime frame
Depression score;Postoperative analgesic pump dosage;VAS score;Plasma BDNF factor levels;intraoperative (Operation time, perioperative heart rate and blood pressure changes, intraoperative oxygen saturation);Adverse reactions;

Countries

China

Contacts

Public ContactYanqiu Ai

The First Affiliated Hospital of Zhengzhou University

aiyanqiu@163.com+86 13607690334

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026